Kraig Biocraft Laboratories (KBLB) Capital Expenditures (2010 - 2025)

Kraig Biocraft Laboratories (KBLB) posted Capital Expenditures of $1612.0 for Q4 2025, down 90.65% sequentially from $17233.0 in Q4 2021.

Kraig Biocraft Laboratories (KBLB) Capital Expenditures (2010 - 2025) Analysis & Trends

Kraig Biocraft Laboratories has reported Capital Expenditures for 9 years, with the latest figure at $1612.0 in Q4 2025.

Quarterly Capital Expenditures changed N/A year-over-year to $1612.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $18845.0 (changed N/A YoY) and the FY2025 annual result came in at $5395.0, up 27.24% from the prior year.
Capital Expenditures slipped to $1612.0 in Q4 2025 per KBLB's latest filing, from $17233.0 in the prior quarter.
Over five years, Capital Expenditures peaked at $74801.0 in Q3 2021 and troughed at $1612.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capex (Qtr)
1	Linde	225.67 Bn	220.77 Bn	4.43 Bn	1.44 Bn
2	Sherwin Williams	84.74 Bn	84.44 Bn	3.34 Bn	108.40 Mn
3	Ecolab	78.90 Bn	73.77 Bn	1.95 Bn	-
4	Air Products & Chemicals	68.19 Bn	67.21 Bn	1.04 Bn	995.70 Mn
5	Ppg Industries	25.36 Bn	23.77 Bn	1.81 Bn	113.00 Mn
6	Chemical & Mining Co Of Chile	23.48 Bn	19.61 Bn	778.60 Mn	-
7	LyondellBasell Industries	21.91 Bn	19.28 Bn	2.04 Bn	270.00 Mn
8	International Flavors & Fragrances	21.51 Bn	20.94 Bn	853.00 Mn	136.00 Mn
9	DuPont de Nemours	18.83 Bn	17.09 Bn	639.00 Mn	76.00 Mn
10	Kraig Biocraft Laboratories	103.15 Mn	103.15 Mn	-	-

Download Data